EcoDrugPlus

Mapk Activated Protein Kinase 5

Ensembl ID : ENSBTAG00000009346
Gene Symbol: MAPKAPK5
13 Enzyme and pathways 5 Cross references
190 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSBTAG00000019933
Gene Symbol: MKNK1
12 Enzyme and pathways 5 Cross references
180 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSBTAG00000018049
Gene Symbol: MKNK2
5 Cross references
233 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member

Ensembl ID : ENSBTAG00000015154
Gene Symbol: MCL1
4 Cross references
255 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSBTAG00000010422
Gene Symbol: MDM2
29 Enzyme and pathways 5 Cross references
257 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSBTAG00000006161
Gene Symbol: MET
28 Enzyme and pathways 5 Cross references
220 Possible Orthologues:

Mpl Proto-Oncogene, Thrombopoietin Receptor

Ensembl ID : ENSBTAG00000003781
Gene Symbol: MPL
5 Cross references
198 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSBTAG00000009928
Gene Symbol: MLST8
21 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSBTAG00000020632
Gene Symbol: NQO1
4 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSBTAG00000018540
Gene Symbol: NOX4
4 Enzyme and pathways 5 Cross references
162 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSBTAG00000019255
Gene Symbol: NFE2L2
9 Enzyme and pathways 5 Cross references
228 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSBTAG00000044146
Gene Symbol: NPC1L1
3 Enzyme and pathways 5 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).